Cargando…
Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
Cardiac hypertrophy is an adaptive change in response to pressure overload, however the hypertrophy may evolve toward heart failure if cannot be corrected as soon as possible. The dysfunction of peroxisome proliferator-activated receptor-α (PPARα) plays a key role in cardiac hypertrophy. In the pres...
Autores principales: | Gao, Hui, Tian, Kunming, Meng, Yichong, Liu, Xueping, Peng, Yingfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035553/ https://www.ncbi.nlm.nih.gov/pubmed/35479323 http://dx.doi.org/10.3389/fphar.2022.865434 |
Ejemplares similares
-
Insight into the Protective Effect of Salidroside against H(2)O(2)-Induced Injury in H9C2 Cells
por: Gao, Hui, et al.
Publicado: (2021) -
Effect of salidroside on lung injury by upregulating peroxisome proliferator-activated receptor γ expression in septic rats
por: LIU, MING-WEI, et al.
Publicado: (2014) -
Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
por: Jen, Hsu-Lung, et al.
Publicado: (2016) -
The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
por: Gao, Jianjun, et al.
Publicado: (2022) -
Rosmarinic Acid Protects against Inflammation and Cardiomyocyte Apoptosis during Myocardial Ischemia/Reperfusion Injury by Activating Peroxisome Proliferator-Activated Receptor Gamma
por: Han, Jichun, et al.
Publicado: (2017)